Kosé is developing personalized skin care using consumers’ own iPS cells via Global Cosmetic Industry

Kosé is partnering with I Peace, Inc. and Reju, Inc. to develop personalized beauty products comprising iPSF (an induced pluripotent stem [iPS] cell extract) derived from customers’ own blood-drawn cells.

This process will reportedly optimize dosages and textures for each consumer; finished products will reportedly be “provided through medical institutions under medical supervision,” per Kosé.

By the end of 2024, iPSF-based formulations will commence demonstrating testing in Japan.

Read more

Recent Posts

We Are Testing at HPCI India 2025

HPCI India has been an Industry-Connect Partner for 10+ years and has established itself as…

ADAT, experts in clinical data certification and analysis since 25 years

Welcome to ADAT Europe At ADAT, we are dedicated to providing state-of-the-art solutions in data…

We Are Testing at in-cosmetics Asia 2024 – The best place to talk about testing

in-cosmetics Asia is the leading personal care and cosmetic ingredient event in Asia Pacific, bringing…